Skip to search formSkip to main contentSkip to account menu

Venous Vasodilation [PE]

Known as: Venous Vasodilation 
National Institutes of Health

Related topics

Related topics

29 relations
0.5 ML Alprostadil 0.02 MG/ML Prefilled Syringe24 HR Isosorbide Mononitrate 60 MG Extended Release Oral Tablet250 ML Nitroglycerin 0.4 MG/ML InjectionAlprostadil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Model of the Transient Neurovascular Response Based on Prompt Arterial Dilation
Brief neural stimulation results in a stereotypical pattern of vascular and metabolic response that is the basis for popular… 
2011
2011
Characterising the time-course of microvascular vasodilator responses in humans using Laser Doppler Fluximetry and iontophoresis.
2004
2004
Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans
SummaryIn recent years, evidence from various animal experiments has accumulated that emphasizes the role of endothelin-1 in the… 
Highly Cited
2003
Highly Cited
2003
Nitric oxide regulates retinal vascular tone in humans.
The purpose of the present study was to investigate the contribution of basal nitric oxide (NO) on retinal vascular tone in… 
2001
2001
Magnetic resonance imaging findings before and after treatment of spontaneous intracranial hypotension
The syndrome of spontaneous intracranial hypotension is characterised by postural headache, low CSF pressure, and MRI findings of… 
Review
1998
Review
1998
Treatment of Chronic Myocardial Ischemia: Rationale and Treatment Options
A rational approach to the treatment of chronic myocardial ischemia requires an appreciation of the pathophysiology of coronary… 
1995
1995
779-1 Vasodilator Effects of the Endothelin-1 Receptor Antagonist Bosentan in Patients with Severe Chronic Heart Failure
1989
1989
[Hemodynamic effects of the new phosphodiesterase inhibitor enoximone in heart surgery patients].
The new phosphodiesterase-III inhibitor (PDI) enoximone is a non-catecholamine, non-glycoside cardiotonic agent with concomitant… 
1988
1988
Cardiovascular pharmacology of RS-1893, an orally active cardiotonic agent with arterial and venous vasodilator actions.
RS-1893, 2-[2-chloro-4-(2,3,4,5-tetrahydro-3-oxo-6-pyridazinyl)]-phenoxy-N- (2-(2-morpholinoethyl)-acetamide, is a newly… 
1982
1982
Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)